Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

Lock-in Agreement Extension

27 Feb 2023 07:00

RNS Number : 0585R
Clean Power Hydrogen
27 February 2023
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

27 February 2023

 

Clean Power Hydrogen Plc

("CPH2", the "Company" or the "Group")

 

Signature of Lock-in Agreement Extension

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), announces that it has entered into Deeds of Amendment (the "Amendments") relating to the lock-in agreements agreed with Jon Duffy, CEO, and a number of other shareholders, including the Company's founders, at the time of the Company's admission to AIM in February 2022.

 

Under the terms of the Amendments, each of Jon Duffy, Clive Brook, Joe Scott, Nigel Williamson and Henry Price have agreed not to dispose of any of the Ordinary Shares held by them (or enter into a transaction with the same economic effect) before the earlier of:

(A) 12 months from 16 February 2023; or

(B) the completion of a Site Acceptance Test with one or more customers, to that customer's satisfaction (covering full capacity 'Mark 1' MFE 220 customer owned units); or

(C) the closing mid-market share price of CPH2 being in excess of 55p for at least 20 consecutive trading days (together, the "Conditions").

 

The Amendment agreed with Jon Duffy permits him to sell a limited number of Ordinary Shares to cover the cost of exercising any existing share options during the restricted period and the associated tax burden.

 

Each of the parties outlined above has also undertaken to not dispose of their Ordinary Shares in the 12-month period following the first satisfaction of any such Condition, other than through Cenkos Securities plc on an orderly market basis.

 

The Company has also entered into Amendments with Rodney Brook and Charles Munroe pursuant to which each individual has agreed not to dispose of more than 10 per cent. of their current holding prior to one of the Conditions being met.

 

In aggregate, the Amendments cover 97,424,617 Ordinary Shares in the Company, which equates to approximately 37% of the current issued share capital of the Company.

 

 

Jon Duffy, Chief Executive Officer of CPH2, commented:

 

"The Directors, founders and related parties, many of whom were instrumental to the initial growth of CPH2, are pleased to show their support in entering into new lock-in arrangements which demonstrate their commitment to CPH2 and belief in the ultimate value of the Company. With a significant pipeline of potential orders and a clearly defined strategy to our target production capacity of 4GW by 2030, we remain extremely positive about the future of the Company as we begin commercial production from our units this year."

 

 

For more information, please contact:

 

Clean Power Hydrogen Plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cenkos Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Billy Clegg

Owen Roberts

Lily Pettifar

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZZLDVGFZM
Date   Source Headline
5th Jun 20269:00 amRNSOperational Update
29th May 20267:30 amRNSSuspension - Clean Power Hydrogen PLC
29th May 20267:00 amRNS1MW MFE220 Factory Acceptance Test update
27th Apr 20267:00 amRNSMemorandum of Understanding with ABE GRUPPE GmbH
7th Apr 20267:00 amRNSMemorandum of Understanding with Koch Modular
30th Mar 20267:00 amRNSOperations & Trading Update
24th Mar 20267:00 amRNSMemorandum of Understanding with Siemens
19th Feb 20267:00 amRNS-RInvestor Webinar
29th Jan 20267:00 amRNSAppointment of Joint Broker
18th Dec 20257:00 amRNSSignificant Milestones Delivered
5th Nov 20257:00 amRNS-RMello2025 Investor Event
24th Oct 20257:00 amRNSAward under Salary Sacrifice Scheme
3rd Oct 20257:00 amRNSAward under the Company’s Long-Term Incentive Plan
30th Sep 20257:00 amRNSInterim Results
26th Sep 20257:00 amRNSAppointment of Chief Operations Director
26th Sep 20257:00 amRNSTR-1: Notification of major holdings
24th Sep 20253:58 pmRNSTR-1: Notification of major holdings
24th Sep 20253:48 pmRNSTR-1: Notification of major holdings
24th Sep 20253:48 pmRNSTR-1: Notification of major holdings
24th Sep 20253:44 pmRNSTR-1: Notification of major holdings
24th Sep 20253:41 pmRNSTR-1: Notification of major holdings
18th Sep 202512:26 pmRNSResult of General Meeting and Total Voting Rights
4th Sep 20257:00 amRNSResults of Oversubscribed Retail Offer
28th Aug 20254:35 pmRNSRetail Offer to Raise up to £300,000
28th Aug 20254:13 pmRNSResult of Placing and Subscription
28th Aug 20257:00 amRNSProposed Placing, Subscription, and Retail Offer
31st Jul 20257:00 amRNSCorporate Update and Proposed Fundraising
1st Jul 20257:00 amRNSWastewater Treatment Efficiency Gains
27th Jun 20257:00 amRNSManufacturing Partnership with Kenera
23rd Jun 20257:00 amRNSLicenced Manufacturing Partnership with Hidrigin
19th Jun 20251:08 pmRNSResult of AGM
16th Jun 20257:00 amRNSMemorandum of Understanding with Constant Energy
5th Jun 20257:00 amRNS2025 Save as You Earn Scheme
30th May 20257:00 amRNSAwards under the Long-Term Incentive Plan
21st May 20257:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20257:00 amRNS-RLongspur Research initiates coverage on CPH2
7th May 202511:23 amRNSSite Acceptance Test for MFE110 electrolyser
1st May 20257:00 amRNSFinal Results
22nd Apr 20257:00 amRNSNotice of Results
22nd Apr 20257:00 amRNSAppointment of Chief Commercial Officer
12th Mar 20257:00 amRNSLevel 2 of Site Acceptance Test Completed
24th Feb 20257:00 amRNSLevel 1 of Site Acceptance Test Completed
16th Jan 20259:21 amRNSIssue of Ordinary Shares
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.